28077724|t|TREM2 Promotes Microglial Survival by Activating Wnt/beta-Catenin Pathway.
28077724|a|Triggering Receptor Expressed on Myeloid cells 2 (TREM2), which is expressed on myeloid cells including microglia in the CNS, has recently been identified as a risk factor for Alzheimer's disease (AD). TREM2 transmits intracellular signals through its transmembrane binding partner DNAX-activating protein 12 (DAP12). Homozygous mutations inactivating TREM2 or DAP12 lead to Nasu-Hakola disease; however, how AD risk-conferring variants increase AD risk is not clear. To elucidate the signaling pathways underlying reduced TREM2 expression or loss of function in microglia, we respectively knocked down and knocked out the expression of TREM2 in in vitro and in vivo models. We found that TREM2 deficiency reduced the viability and proliferation of primary microglia, reduced microgliosis in Trem2-/- mouse brains, induced cell cycle arrest at the G1/S checkpoint, and decreased the stability of beta-catenin, a key component of the canonical Wnt signaling pathway responsible for maintaining many biological processes, including cell survival. TREM2 stabilized beta-catenin by inhibiting its degradation via the Akt/GSK3beta signaling pathway. More importantly, treatment with Wnt3a, LiCl, or TDZD-8, which activates the beta-catenin-mediated Wnt signaling pathway, rescued microglia survival and microgliosis in Trem2-/- microglia and/or in Trem2-/- mouse brain. Together, our studies demonstrate a critical role of TREM2-mediated Wnt/beta-catenin pathway in microglial viability and suggest that modulating this pathway therapeutically may help to combat the impaired microglial survival and microgliosis associated with AD.SIGNIFICANCE STATEMENT Mutations in the TREM2 (Triggering Receptor Expressed on Myeloid cells 2) gene are associated with increased risk for Alzheimer's disease (AD) with effective sizes comparable to that of the apolipoprotein E (APOE) epsilon4 allele, making it imperative to understand the molecular pathway(s) underlying TREM2 function in microglia. Our findings shed new light on the relationship between TREM2/DNAX-activating protein 12 (DAP12) signaling and Wnt/beta-catenin signaling and provide clues as to how reduced TREM2 function might impair microglial survival in AD pathogenesis. We demonstrate that TREM2 promotes microglial survival by activating the Wnt/beta-catenin signaling pathway and that it is possible to restore Wnt/beta-catenin signaling when TREM2 activity is disrupted or reduced. Therefore, we demonstrate the potential for manipulating the TREM2/beta-catenin signaling pathway for the treatment of AD.
28077724	0	5	TREM2	Gene	83433
28077724	53	65	beta-Catenin	Gene	12387
28077724	75	123	Triggering Receptor Expressed on Myeloid cells 2	Gene	83433
28077724	125	130	TREM2	Gene	83433
28077724	251	270	Alzheimer's disease	Disease	MESH:D000544
28077724	272	274	AD	Disease	MESH:D000544
28077724	277	282	TREM2	Gene	83433
28077724	385	390	DAP12	Gene	22177
28077724	427	432	TREM2	Gene	83433
28077724	436	441	DAP12	Gene	22177
28077724	450	469	Nasu-Hakola disease	Disease	MESH:C536329
28077724	484	486	AD	Disease	MESH:D000544
28077724	521	523	AD	Disease	MESH:D000544
28077724	598	603	TREM2	Gene	83433
28077724	712	717	TREM2	Gene	83433
28077724	764	769	TREM2	Gene	83433
28077724	851	863	microgliosis	Disease	
28077724	867	872	Trem2	Gene	83433
28077724	876	881	mouse	Species	10090
28077724	971	983	beta-catenin	Gene	12387
28077724	1120	1125	TREM2	Gene	83433
28077724	1137	1149	beta-catenin	Gene	12387
28077724	1188	1191	Akt	Gene	11651
28077724	1192	1200	GSK3beta	Gene	56637
28077724	1253	1258	Wnt3a	Gene	22416
28077724	1260	1264	LiCl	Chemical	MESH:D018021
28077724	1269	1275	TDZD-8	Chemical	MESH:C494356
28077724	1297	1309	beta-catenin	Gene	12387
28077724	1373	1385	microgliosis	Disease	
28077724	1389	1394	Trem2	Gene	83433
28077724	1418	1423	Trem2	Gene	83433
28077724	1427	1432	mouse	Species	10090
28077724	1493	1498	TREM2	Gene	83433
28077724	1512	1524	beta-catenin	Gene	12387
28077724	1670	1682	microgliosis	Disease	
28077724	1699	1714	AD.SIGNIFICANCE	Disease	MESH:D000544
28077724	1742	1747	TREM2	Gene	83433
28077724	1749	1797	Triggering Receptor Expressed on Myeloid cells 2	Gene	83433
28077724	1843	1862	Alzheimer's disease	Disease	MESH:D000544
28077724	1864	1866	AD	Disease	MESH:D000544
28077724	1915	1931	apolipoprotein E	Gene	11816
28077724	1933	1937	APOE	Gene	11816
28077724	2027	2032	TREM2	Gene	83433
28077724	2112	2117	TREM2	Gene	83433
28077724	2146	2151	DAP12	Gene	22177
28077724	2171	2183	beta-catenin	Gene	12387
28077724	2230	2235	TREM2	Gene	83433
28077724	2281	2283	AD	Disease	MESH:D000544
28077724	2318	2323	TREM2	Gene	83433
28077724	2375	2387	beta-catenin	Gene	12387
28077724	2445	2457	beta-catenin	Gene	12387
28077724	2473	2478	TREM2	Gene	83433
28077724	2574	2579	TREM2	Gene	83433
28077724	2580	2592	beta-catenin	Gene	12387
28077724	2632	2634	AD	Disease	MESH:D000544
28077724	Association	12387	56637
28077724	Association	56637	83433
28077724	Association	11651	83433
28077724	Association	11651	12387
28077724	Association	MESH:C536329	22177
28077724	Association	MESH:C494356	83433
28077724	Association	MESH:D000544	83433
28077724	Positive_Correlation	12387	22416
28077724	Association	22177	83433
28077724	Association	MESH:D000544	12387
28077724	Association	MESH:D018021	83433
28077724	Positive_Correlation	MESH:D018021	12387
28077724	Association	MESH:C536329	83433
28077724	Positive_Correlation	MESH:C494356	12387
28077724	Positive_Correlation	12387	83433

